American Society of Health-System Pharmacists, Dec. 3-7Last Updated: December 08, 2017.
The annual meeting of the American Society of Health-System Pharmacists was held from Dec. 3 to 7 in Orlando, Fla., and attracted more than 20,000 participants from around the world, including pharmacy specialists, technicians, and other health care professionals. The conference featured educational sessions which covered trends in pharmaceutical research and provided insight into effective and safe medication use and improving patient care.
During one education session, Ernest Dole, Pharm.D., of the University of New Mexico Hospitals in Albuquerque, and Jeffrey Fudin, Pharm.D., of the Stratton Veteran's Administration Medical Center in Albany, N.Y., debated the pros and cons of the use of naloxone, an opioid antagonist used for complete or partial reversal of opioid overdose.
During the session, Dole discussed criteria and concerns tied to co-prescribing naloxone, and provided insight into how to select from the available naloxone preparations for a given clinical situation.
Fudin discussed the lifesaving benefits of naloxone. "As a profession, we need to eliminate the stigma of addiction and support its treatment as a disease or medical disorder," he said. "Pharmacists have an ethical obligation to support 'the welfare of humanity and relief of suffering' as their primary concerns."
Fudin disclosed a financial relationship with Kaléo Pharma, a manufacturer of naloxone.
The presenters of another education session discussed managing pain in opioid use disorder (OUD).
Pharmacy specialists were provided with insight into the use of analgesics for chronic pain and identification of the presence of OUD and therapeutic options, as well as with approaches to address acute pain in the OUD patient. They were also offered recommendations on how and when to use opioids in OUD patients.
"Use functional goals in order to assess benefits of therapy. Consider opioid therapy for chronic pain only when nonpharmacologic and pharmacologic options have been exhausted," the presenters suggested. "Buprenorphine may be considered as a frontline analgesic in patients with OUD and chronic pain. Medications effective to treat OUD yield similar or more impressive outcomes than medications used to treat other chronic illnesses."
Another session was presented by Marylyn D. Ritchie, Ph.D., M.S., B.S., of the Biomedical and Translational Informatics Institute at Geisinger Health in Danville, Pa. Ritchie discussed pharmacogenomics -- the study of how the genome plays a role in an individual's response to pharmacological treatments -- and how it is beginning to play a larger role in personalized medicine.
A number of presentations during the conference focused on the impact of stress on pharmacy specialists. One session focused on effective ways for pharmacists to manage their career and personal life (Gems for Success: Integrating and Managing Your Life and Career). A couple of other presentations focused on working as a team (Team Work Coaching: Getting Your People to Play Nice in the Sandbox and OWN Their Jobs! and The One Percent Quest to Better Your Best: Staying Resilient and Productive!). In addition, another presentation focused on engaging residents and students in the learning process to become effective pharmacy professionals (Engage With Your Learners: It's Time for Pharmacy Preceptors Phamily Pheud!).
ASHP Launches Pharmacy Technician Forum
THURSDAY, Dec. 7, 2017 (HealthDay News) -- A pharmacy technician forum, which aims to provide a voice for practicing technicians and improve engagement in the American Society of Health-System Pharmacists (ASHP), has been created by the ASHP Board of Directors and launched at the mid-year clinical meeting and exhibition of the ASHP, held from Dec. 3 to 7 in Orlando, Fla.
ASHP + Partners Urge Congress Action on Drug Shortages
WEDNESDAY, Dec. 6, 2017 (HealthDay News) -- Congress has been urged to take immediate action in addressing the public health crisis associated with persistent shortages of critical medications, according to an announcement made at the mid-year clinical meeting and exhibition of the American Society of Health-System Pharmacists (ASHP), held from Dec. 3 to 7 in Orlando, Fla.
ASHP: Joint Commission Impact on Pain Management Discussed
TUESDAY, Dec. 5, 2017 (HealthDay News) -- Insights into the impact of The Joint Commission's standards on pain management were presented during an educational session held at the mid-year clinical meeting and exhibition of the American Society of Health-System Pharmacists, held from Dec. 3 to 7 in Orlando, Fla.
ASHP: Key Role for Pharmacists in Natural, Man-Made Disasters
TUESDAY, Dec. 5, 2017 (HealthDay News) -- Pharmacy specialists play a critical role in preparing for and responding to disastrous events, according to an educational session held at the mid-year clinical meeting and exhibition of the American Society of Health-System Pharmacists, held from Dec. 3 to 7 in Orlando, Fla.
ASHP Addresses Small-Volume Parenteral Solution Shortages
MONDAY, Dec. 4, 2017 (HealthDay News) -- A fact sheet to aid health care organizations in managing shortages of small-volume parenteral (SVP) solutions has been developed by the American Society of Health-System Pharmacists (ASHP) and the University of Utah Drug Information Service. This resource was presented at the mid-year clinical meeting and exhibition of the ASHP, held from Dec. 3 to 7 in Orlando, Fla.
|Previous: SABCS: 3D Mammography Could Help Rein in Screening Costs||Next: Influenza Picking Up in U.S., Predominantly A(H3N2)|
Reader comments on this article are listed below. Review our comments policy.